Wren Laboratories Receives NYSDOH-CLEP Approval for PROSTest™, Transforming Prostate Cancer Detection
Wren Laboratories, a leader in molecular diagnostics, is proud to announce that its breakthrough liquid biopsy test, PROSTest™, has been approved by the New York State Department of Health Clinical Laboratory Evaluation Program (NYSDOH-CLEP).
25-Apr-2025 10:20 AM EDT
Add to Favorites